Smith & Nephew plc

NYSE
SNN
Stock
Yield per half year: +15.6%
Dividend yield: 2.55%
Sector: Healthcare

Smith & Nephew plc

34.0034.0032.0032.0030.0030.0028.0028.0026.0026.0024.0024.0022.0022.00Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
6/10
26.15 52.65 -50.33% 35.2 -25.71%
P/S 1.85 4.03 -54.02%
P/BV 2.05 10.87 -81.17%
P/FCF 19.65 39.64 -50.42%
Ev/Ebitda 10.89 16.12 -32.4%
Ev/S 2.32 4.35 -46.7%
Ev/FCF 22.24 52.31 -57.49%
E/P 0.0346 0.2095 -83.48%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
7/10
21.29 19.07 11.64% 18.54 +14.85%
ROE 7.86 -83.32 -109.43%
ROA 4.05 6.38 -36.49%
ROIC 6.73 15.06 -55.31%
ROS 7.09 9.34 -24.05%
ROCE 12.48 84.77 -85.28%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
5/10
2.68 1.02 163.63% 2.81 -4.51%
Nеt Debt/Ebitda 2.18 1.4 56.09%
Debt/Ratio 0.3207 0.2741 17.02%
Debt/Equity 0.9666 15.68 -93.83%
Debt/Net Income 8.06 6.8 18.56%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
6.38/10
2.55 1.28 98.8% 2.67 -4.65%
Number of years of dividend growth 0 6.75 -100%
DSI 1 0.7413 34.89%
Average dividend growth 0.8 -4.1 -119.49%
Average percentage for 5 years 2.67 1.33 100.38%
Average percentage for payments 56.5 44.08 28.16%
Difference from average difference in sector 1.27

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
4/10
27.41 12.47 119.81%
Growth impulse Ebitda in 5 years 40.09 -86.3 -146.45%
Growth impulse Net Income in 5 years -8.04 -75.86 -89.4%
Growth impulse FCF in 5 years 23.17 -79.28 -129.23%
Growth impulse EPS in 5 years -7.84 4.34 -280.65%
IP Score
5.02/10

Similar companies

Humana

Bristol-Myers

PFIZER

Johnson & Johnson

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription